Ambu A/S (OTCMKTS:AMBBY) Hits New 52-Week Low – Time to Sell?

Ambu A/S Unsponsored ADR (OTCMKTS:AMBBY) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $10.3162 and last traded at $10.3162, with a volume of 1200 shares trading hands. The stock had previously closed at $10.6540.

Ambu A/S Stock Performance

The stock has a market capitalization of $2.42 billion, a PE ratio of 33.28 and a beta of 0.98. The company has a quick ratio of 1.67, a current ratio of 2.86 and a debt-to-equity ratio of 0.08. The stock has a fifty day moving average of $12.51 and a 200-day moving average of $13.82.

Ambu A/S (OTCMKTS:AMBBY) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $0.07 earnings per share for the quarter. The company had revenue of $242.85 million for the quarter. Ambu A/S had a return on equity of 9.15% and a net margin of 8.86%.

About Ambu A/S

Ambu A/S is a Denmark-based medical device company specializing in single-use diagnostic and life-supporting equipment for hospitals, clinics and emergency services. The company’s core focus lies in developing products that enhance patient safety, streamline clinical workflows and reduce the risk of cross-contamination. Ambu’s offerings span critical care solutions such as anesthesia and respiratory care devices, as well as advanced endoscopy systems for minimally invasive diagnostics and therapies.

Within its anesthesia and respiratory care segment, Ambu is known for its market-leading disposable resuscitators—commonly referred to as “Ambu bags”—as well as a range of airway management products, including laryngeal masks and endotracheal tubes.